BCL2 and colorectal carcinoma: YAP knockdown downregulated BCL2 expression to promote Caspase-3 cleavage and GSDME cleavage and rescued the inhibition of chemotherapy-induced pyroptosis and chemoresistance of F. nucleatum, which may be used as a potential molecular target for CRC treatment.